Immunology
Blood Test Differentiates Parkinson's from Similar Diseases
In early stages of disease, it can be difficult to differentiate between Parkinson's disease and atypical parkinsonism disorders (APDs) like multiple system atrophy, progressive supranuclear palsy and corticobasal degeneration, because symptoms can overlap. More...22 Feb 2017
Immunosignaturing Platform Provides Pre-Symptom Diagnostics
Researchers have developed an immunosignature profiling technology aimed to provide people with a means of monitoring their health status and a means for early detection of disease by rapidly testing for many diseases at once from a single drop of blood. In addition, the versatile technology could be used to secure a nation’s blood supply or give early warning of a disease epidemic. More...21 Feb 2017
Marker Detection Leads to Earlier Pancreatic Cancer Testing
With nanoplasmonic technology that enabled quantification of tumor-derived extracellular vesicles (EVs) in patient blood plasma microsamples, researchers have developed a noninvasive, inexpensive, rapid test for early diagnosis of pancreatic cancer (PC) as well as for monitoring of treatment-response and cancer burden in patients with PC. More...15 Feb 2017
Biomarker Predicts Outcome in Persistently Unconscious Patients
Prediction of neurological outcome is a crucial part of post cardiac arrest care and prediction in patients remaining unconscious and/or sedated after rewarming from targeted temperature management (TTM) remains difficult. More...09 Feb 2017
Seropositivity Thresholds Defined for Use in Trachoma Elimination Studies
Trachoma is caused by ocular infection with the bacterium Chlamydia trachomatis and it is the leading infectious cause of blindness worldwide. It is estimated that over 200 million people in 42 countries are at risk from trachoma blindness. More...01 Feb 2017
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Blood Glucose Test Strip
AutoSense Test
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
In Other News
Rapid Method Determines Free and Total PSA in Serum
Serological Test Differentiates Zika from Dengue Infections
Diagnostic Accuracy Compared for Biomarkers of Acute Heart Failure
Novel Point-Of-Care Test Kit for Procalcitonin Evaluated
Novel Bioassay Developed to Determine Glucocorticoid Sensitivity
Novel Procalcitonin Immunoassay Analytically Evaluated
Early Biomarker Found for Sepsis-Induced Kidney Injury
New Biomarker Reported for Severe Intracerebral Hemorrhage
New Diagnostic Tests Improve Care for Heart Failure Patients
Brain Protein May Help Assess Recovery Time Following Concussion
Blood Test Leads to Earlier Detection of Lung Cancer
New Automated Periostin Immunoassay Developed
Abnormal Immune Cells Involved in Causing Fibrosis
DNA Levels in Blood Correlated with Ovarian Cancer Outcomes
Common Bacteria of Gum Disease Linked to Rheumatoid Arthritis
Inflammatory Markers Predict Risk of Morbidity and Mortality
Stem Cell-Based Test Predicts Leukemia Patients' Response to Therapy
Performance of Second Generation Cortisol Assay Evaluated
FDA Clears Assay for Herpes Simplex and Varicella-Zoster Viruses
Multiparametric Serological Testing Aids Diagnosis of Autoimmune Encephalitis
Variations in T-cells Identifies Susceptibility to Disease
Congenital Cytomegalovirus Infection Predicted in High-Risk Pregnant Women
Peptide Serum Markers Predict Type 1 Diabetes
The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.